The diagnosis comes before the procedure
“Liver tumour” describes a finding, not a single disease. Some liver lesions are benign. Cancer may begin in the liver or spread there from another organ. These situations can have very different treatments.
Before considering a procedure, the team needs to understand the tumour type, where it is, how much disease is present and how well the rest of the liver works. The person’s general health and goals matter too. A scan showing a mass does not automatically establish the diagnosis.
CT or MRI, blood tests, previous records and sometimes biopsy help answer these questions. A biopsy is not always necessary; some liver cancers can be diagnosed from characteristic imaging in the appropriate clinical setting.
The plan may be discussed by a team including liver specialists, surgeons, oncologists, radiologists and interventional radiologists. Treatment decisions should fit together rather than focus on a single available technique.
How the main options fit together
Surgery may remove a tumour in selected patients when enough functioning liver can remain. Liver transplantation is an option for particular cancers and circumstances under specialist criteria. These choices require careful assessment of both cancer and liver disease.
Medicines, including systemic cancer treatments, can treat disease beyond a single local area. Radiotherapy may have a role in selected cases. The options differ between primary liver cancer and spread from another cancer, and between stages of disease.
Image-guided treatments target an area through a needle or blood vessel. They may be used with different goals: treating a small local tumour, controlling disease, helping a person reach another treatment, or supporting a surgical plan. A local treatment is not automatically a replacement for medicines or surgery.
Ask the team to state the goal plainly. Treatment intended to control disease is different from treatment given with curative intent, and neither term guarantees what will happen.
Ablation and arterial treatments
Ablation uses a probe guided into or beside a tumour, often to create heat that damages the target tissue. Size, location and proximity to important vessels, bile ducts and other organs influence whether it can be used safely. A suitable treatment margin is part of planning.
Chemoembolisation, often called TACE, delivers chemotherapy and embolic material into selected arteries supplying a tumour. The aim is to concentrate treatment and reduce arterial supply to the target. Liver function and the pattern of disease are central to selection.
Other arterial approaches exist, including treatments using radiation, but their suitability and availability vary. Mentioning them as treatment options does not establish that every hospital or practitioner provides them.
Portal vein embolisation has a different purpose. It may be used before planned surgery to encourage growth of the portion of liver that will remain. It is not the same as arterial treatment of the tumour and does not itself establish that surgery has become safe.
Recovery, risks and follow-up scans
Hospital observation and recovery vary by the procedure, tumour burden and liver health. Pain, fatigue, nausea or fever can occur after some liver-directed treatments. The team should explain what is expected and which symptoms need urgent assessment.
Risks can include bleeding, infection, damage to nearby structures, contrast-related problems and deterioration in liver function. Some complications can be serious. Existing cirrhosis or other illnesses may change the balance of benefit and risk.
Follow-up assesses symptoms, blood tests and imaging. A treated area can remain visible on a scan, so appearance and size alone may not show whether cancer is still active. Repeat treatment or a change in approach may be required.
Severe or worsening pain, persistent high fever, new confusion, vomiting blood or significant deterioration needs urgent medical assessment. Follow the treating team’s discharge advice.
Questions for the treatment team
Bring the full sequence of reports and prior cancer treatment details, rather than only the most recent scan. Clarify whether the tumour has a confirmed diagnosis and whether the plan has been discussed by the relevant specialists.
- What type of tumour is this, and has it spread?
- How well is the remaining liver functioning?
- What is the purpose of the proposed treatment in the wider plan?
- Why is a local procedure being considered now?
- What alternatives include surgery, transplantation, medicines or radiotherapy?
- When will response be assessed, and what happens if the tumour remains active?
It is reasonable to ask how the different clinicians will communicate and who will be the main contact for follow-up. A clear sequence of care matters as much as understanding the individual procedure.
Common questions
Does every liver mass mean cancer?
No. The word “mass” is a description that needs interpretation. Before choosing treatment, clarify whether the diagnosis is confirmed, what type of lesion is present and whether further tests are needed. Previous scans and the clinical background can be important parts of that interpretation.
Is a local procedure the whole cancer treatment?
Sometimes a local treatment has a central role; in other situations it forms only one part of a wider sequence. Ask why it is proposed now and how it fits with surgery, medicines, radiotherapy or another plan. The answer depends on the diagnosis, stage and liver function.
Does a smaller area on the scan prove the cancer is gone?
A treated area requires specialist interpretation, and size is only one feature. Ask the team how response will be judged and when the next scan or blood tests are due. Do not independently stop follow-up because the first report sounds reassuring or the symptoms have improved.
What should the family understand before discharge?
The family should know the medicines, expected recovery symptoms, warning signs, planned follow-up and who is responsible for the next stage of care. If information from different specialists seems inconsistent, ask the team to clarify the shared plan in writing so that avoidable gaps do not develop.
Planning care and follow-up in Ahmedabad
For a planned discussion, gather existing images and reports, earlier discharge summaries, a medicine list and any recent tests already performed. Record the symptoms you want explained and what has changed. Do not arrange another investigation or stop prescribed medicine solely because a website mentions a test or treatment.
If you are travelling from Surat, Vadodara, Rajkot or elsewhere in Gujarat to Ahmedabad, ask the treating team whether the first assessment and any procedure happen on different days. Clarify whether overnight observation, an accompanying adult or a local follow-up arrangement may be needed. Do not plan the return journey around a general recovery estimate.
Before a planned treatment, ask for an individual cost estimate and confirmation of insurance or PM-JAY eligibility from the hospital billing team. A statement that a payment method is available does not establish coverage for a particular procedure. The care plan should also identify who will provide instructions and assess any unexpected symptoms after discharge.
Useful practical questions include when you can work, travel or exercise; what medication changes are needed; and how you will receive follow-up results. Instructions depend on the diagnosis, the procedure and the anaesthesia. A written plan is more useful than assuming that every treatment through a small opening has the same recovery.
See the treatment mechanism
01An artery supplies the tumour
02Drug and embolic material reach it
03Aim: treat the selected tumour area
Treatment through a probe: ablation
01A tumour is identified on imaging
02A probe is guided into the target
03A treatment zone includes a margin
Sources and scope
Educational information prepared 12 September 2026. General information; individual suitability, risks and follow-up require clinical assessment. The references below explain the underlying condition and treatment choices.